Glutamate cysteine ligase modifier (GCLM) subunit gene is not associated with methamphetamine-use disorder or schizophrenia in the Japanese population

Annals of the New York Academy of Sciences

Volumn 1139, Issue , 2008, Pages 63-69

  Kishi, Taro ^a   Ikeda, Masashi ^a   Kitajima, Tsuyoshi ^a   Yamanouchi, Yoshio ^a   Kinoshita, Yoko ^a   Kawashima, Kunihiro ^a   Inada, Toshiya ^b,k   Harano, Mutsuo ^c,k   Komiyama, Tokutaro ^d,k   Hori, Toru ^e,k   Yamada, Mitsuhiko ^e,k   Iyo, Masaomi ^f,k   Sora, Ichiro ^g,k   Sekine, Yoshimoto ^h,k   Ozaki, Norio ^i,k   Ujike, Hiroshi ^j,k   Iwata, Nakao ^a,k  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TEIKYO UNIVERSITY   (Japan)

^c KURUME UNIVERSITY   (Japan)

^d Iida Hospital   (Japan)

^e NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^f CHIBA UNIVERSITY   (Japan)

^g TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^h HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁱ NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^j OKAYAMA UNIVERSITY   (Japan)

^k NONE

more..

Author keywords

Glutamate cysteine ligase modifier (GCLM) subunit gene; Linkage disequilibrium; Methamphetamine use disorder; Schizophrenia; Tagging SNPs

Indexed keywords

GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE; METHAMPHETAMINE;

CASE CONTROL STUDY; CONFERENCE PAPER; CONTROLLED STUDY; DRUG ABUSE; FEMALE; GCLM GENE; GENE; GENE LINKAGE DISEQUILIBRIUM; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; PSYCHOSIS; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 53549107232     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1432.022     Document Type: Conference Paper

References (11)

1. Dringen, R. 2000. Metabolism and functions of glutathione in brain. Prog. Neurobiol 62 : 649 671.
2. Ibi, M. et al. 1999. Depletion of intracellular glutathione increases susceptibility to nitric oxide in mesencephalic dopaminergic neurons. J. Neurochem. 73 : 1696 703.
3. Tosic, M. et al. 2006. Schizophrenia and oxidative stress: glutamate cysteine ligase modifier as a susceptibility gene. Am. J. Hum. Genet. 79 : 586 592.
4. Arinami, T. et al. 2005. Genomewide high-density SNP linkage analysis of 236 Japanese families supports the existence of schizophrenia susceptibility loci on chromosomes 1p, 14q, and 20p. Am. J. Hum. Genet. 77 : 937 944.
5. Nishiyama, T. et al. 2005. Haplotype association between GABAA receptor gamma2 subunit gene (GABRG2) and methamphetamine use disorder. Pharmacogenomics J. 5 : 89 95.
6. Barrett, J.C. et al. 2005. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 : 263 265.
7. Haga, H. et al. 2002. Gene-based SNP discovery as part of the Japanese Millennium Genome Project: identification of 190,562 genetic variations in the human genome. Single-nucleotide polymorphism. J. Hum. Genet. 47 : 605 610.
8. Hirakawa, M. et al. 2002. JSNP: a database of common gene variations in the Japanese population. Nucleic Acids Res. 30 : 158 162.
9. Nakamura, S. et al. 2002. Polymorphism in the 5′-flanking region of human glutamate-cysteine ligase modifier subunit gene is associated with myocardial infarction. Circulation 105 : 2968 2973.
10. Ohashi, J. et al. 2001. Comparison of statistical power between 2 * 2 allele frequency and allele positivity tables in case-control studies of complex disease genes. Ann. Hum. Genet. 65 (Pt 2 197 206.
11. Wall, J.D. & J.K. Pritchard. 2003. Haplotype blocks and linkage disequilibrium in the human genome. Nat. Rev. Genet. 4 : 587 597.